Clover Health Investments, Corp.

CLOVNasdaqCIK 1801170FinancialsFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Reports and events: 149 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Clover Health Investments, Corp., Reports and events
Filed	Form	What it is	Accession number
2022-05-0920:17 ET	10-Q	Quarterly reportPeriod 2022-03-31	0001801170-22-000027
2022-05-0920:03 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001801170-22-000026
2022-02-2821:02 ET	10-K	Annual reportPeriod 2021-12-31	0001801170-22-000015
2022-02-2321:15 ET	8-K	2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001801170-22-000011
2022-01-1913:59 ET	8-K	5.02 Departure or appointment of officers or directors	0001801170-22-000006
2022-01-1421:30 ET	SC 13D/A	Ownership report, active investor, amended	0001341004-22-000011
2021-11-1521:13 ET	S-1	Registration statement	0001628280-21-023372
2021-11-0911:02 ET	10-Q	Quarterly reportPeriod 2021-09-30	0001801170-21-000036
2021-11-0821:05 ET	8-K	2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001801170-21-000034
2021-09-1420:20 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001801170-21-000027
2021-08-2520:10 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001801170-21-000024
2021-08-1623:34 ET	8-K	5.02 Departure or appointment of officers or directors	0001801170-21-000020
2021-08-1323:29 ET	8-K	2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001801170-21-000016
2021-08-1120:16 ET	10-Q	Quarterly reportPeriod 2021-06-30	0001801170-21-000011
2021-08-1120:06 ET	8-K	9.01 Financial statements and exhibits	0001801170-21-000009
2021-07-2212:45 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001193125-21-221445
2021-07-1513:02 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001193125-21-215904
2021-05-1721:19 ET	10-Q	Quarterly reportPeriod 2021-03-31	0000950170-21-000268
2021-05-1712:01 ET	8-K	4.02 Non-reliance on financial statements	0000950170-21-000251
2021-05-1711:32 ET	8-K	2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0000950170-21-000250
2021-04-1513:16 ET	8-K	5.02 Departure or appointment of officers or directors	0001193125-21-117245
2021-04-0101:50 ET	8-K/A	2.02 Results of operations	0001193125-21-102873
2021-04-0101:49 ET	8-K/A	9.01 Financial statements and exhibits	0001193125-21-102870
2021-03-3121:25 ET	10-K	Annual reportPeriod 2020-12-31	0001193125-21-102551
2021-03-3121:17 ET	8-K	5.02 Departure or appointment of officers or directors	0001193125-21-102528
2021-03-2912:31 ET	8-K	7.01 Regulation FD disclosure	0001193125-21-097515
2021-03-0121:47 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001193125-21-063662
2021-03-0121:42 ET	8-K	2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001193125-21-063629
2021-02-0511:15 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001193125-21-029637
2021-02-0511:12 ET	8-K	8.01 Other events	0001193125-21-029629
2021-01-2714:01 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001193125-21-018535
2021-01-1921:21 ET	SC 13D	Ownership report, active investor	0001193125-21-011484
2021-01-1522:24 ET	SC 13D	Ownership report, active investor	0001193125-21-010247
2021-01-1315:40 ET	S-1	Registration statement	0001193125-21-007853
2021-01-1222:18 ET	8-K	1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 4.01 Change of auditor; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.06 Item not in the standard list; 9.01 Financial statements and exhibits	0001193125-21-007348
2021-01-0621:05 ET	8-K	5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results	0001193125-21-003100
2020-12-1413:14 ET	8-K	3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001193125-20-316438
2020-12-1012:42 ET	8-K	1.01 Entry into a material agreement; 9.01 Financial statements and exhibits	0001193125-20-314423
2020-11-1912:34 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001193125-20-297567
2020-11-1622:44 ET	10-Q	Quarterly reportPeriod 2020-09-30	0001104659-20-125176
2020-10-0611:14 ET	8-K	1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001104659-20-112403
2020-08-1320:06 ET	10-Q	Quarterly reportPeriod 2020-06-30	0001104659-20-094660
2020-06-0420:50 ET	10-Q	Quarterly reportPeriod 2020-03-31	0001104659-20-069858
2020-04-3020:20 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001104659-20-054459
2020-04-2421:19 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001104659-20-051086
2020-04-2010:06 ET	S-1/A	Registration statement, amended	0001104659-20-048392
2020-03-1801:56 ET	S-1/A	Registration statement, amended	0001104659-20-034929
2020-03-1100:24 ET	S-1/A	Registration statement, amended	0001104659-20-031529
2020-02-2821:40 ET	S-1	Registration statement	0001104659-20-027174

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.